Glaucoma patients: could this supplement save your sight?

NCT ID NCT07322965

Recruiting now Disease control Sponsor: Institut Catala de Retina Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a daily supplement called BrudyGlauco (containing DHA and citicoline) can help protect eyesight in people with glaucoma. About 108 participants will take either the supplement or a placebo for 12 months. The goal is to see if it slows vision loss and improves quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA NEUROPROTECTION PRIMARY OPEN ANGLE GLAUCOMA (POAG)

Contacts and locations

Locations

Hospital del Mar | Centre Esperança
NOT_YET_RECRUITING

Barcelona, Barcelona, 08024, Spain
Institut Català de Retina
RECRUITING

Barcelona, Barcelona, 08022, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.